JPRN-jRCT2080221483招募中3 期
ong-Term, Open-Label, Safety Study of LY2216684 12 to 18 mg Once Daily as Adjunctive Treatment for Adult Patients with Major Depressive Disorder Who were Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients must have completed previous Study
- •adult male or female outpatients at least 18 years of age or older at the time of informed consent
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
ot ApplicableMajor depressive disorder (MDD)MedDRA version: 14.0Level: LLTClassification code 10025453Term: Major depressive disorder NOSSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2010-020726-18-LTEli Lilly and Company600
进行中（未招募）
不适用
ong-Term, Open-Label, Safety Study of LY2216684 12 to 18 mg Once Daily as Adjunctive Treatment for Patients with Major Depressive Disorder Who are Partial Responders to Selective Serotonin Reuptake Inhibitor TreatmentMajor depressive disorder (MDD)MedDRA version: 14.0Level: LLTClassification code 10025453Term: Major depressive disorder NOSSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2010-020726-18-PTEli Lilly and Company600
已完成
3 期
ong-Term, Open-Label, Safety Study of LY2216684 12 to 18 mg Once Daily as Adjunctive Treatment for Patients with Major Depressive Disorder Who are Partial Responders to Selective Serotonin Reuptake Inhibitor TreatmentNL-OMON36315Eli Lilly20
进行中（未招募）
1 期
ong-Term, Open-Label, Safety Study of LY2216684 12 to 18 mg Once Daily as Adjunctive Treatment for Patients with Major Depressive Disorder Who are Partial Responders to Selective Serotonin Reuptake Inhibitor TreatmentEUCTR2010-020726-18-NLEli Lilly and Company600
进行中（未招募）
不适用
A Long-Term Study in SchizophreniaMedDRA version: 14.1Level: PTClassification code 10039626Term: SchizophreniaSystem Organ Class: 10037175 - Psychiatric disordersSchizophreniaEUCTR2011-004327-13-ATEli Lilly and Company282